The genetic landscape of pancreatic tumor genomes is characterized by the presence of four frequently-mutated genes, represented by: KRAS (90%), CDKN2A (p16, 90%), TP53 (70%) and SMAD4 (55%). Here, KRAS is linked to pancreatic neoplasm.